📰 Nusayba Bagegni News
Nusayba Bagegni News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nusayba Bagegni. Real-time updates on events, politics, business and more.
May 16, 2023
Nusayba Bagegni, MD, details ongoing research and possibilities for the treatment landscape in the future, which includes investigating escalating approaches through more research in clinical trials.
May 6, 2023
Nusayba Bagegni, MD, discusses the prevalence of interstitial lung disease in patients with HER2-positive breast cancer treated with trastuzumab deruxtecan.
May 4, 2023
Nusayba Bagegni, MD, discusses updated efficacy and biomarker data from the phase 2 APT and ATEMPT trials in early-stage HER2-positive breast cancer.
April 18, 2023
This condition can develop as a result of surgery, radiation, and cancer itself.
November 24, 2021
UPPSALA, SWEDEN / ACCESSWIRE / November 24, 2021 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II)Biovica, active in cancer diagnostics, today announces initiation of the TK IMPACT study